Sarepta Therapeutics, Inc. (SRPT)
16.19
+0.10
(+0.62%)
USD |
NASDAQ |
Mar 05, 14:41
Sarepta Therapeutics Free Cash Flow : -332.39M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 12.36B |
| Pfizer Inc. | 9.076B |
| REGENXBIO, Inc. | -106.28M |
| Keros Therapeutics, Inc. | 87.08M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 126.93M |
| Cash from Investing (Quarterly) | 96.21M |
| Cash from Financing (Quarterly) | -34.94M |
| Free Cash Flow Per Share (Quarterly) | 1.176 |
| Free Cash Flow to Equity (Quarterly) | 333.84M |
| Free Cash Flow to Firm (Quarterly) | 144.28M |
| Free Cash Flow Yield | -20.08% |